A closer look at Doleac and Mukherjee (2022) and the effects of naloxone access laws on opioid ER admissions.
In their 2022 study, 'The Effects of Naloxone Access Laws on Opioid Abuse, Mortality, and Crime,' Doleac and Mukherjee conclude that broadening access to a life‐saving drug—naloxone—does not reduce opioid‐related mortality as the drug simultaneously encourages riskier drug use. I show issues with th...
| Publicado en: | Economic Inquiry Vol. 64; no. 1; pp. 54 - 88 |
|---|---|
| Autor principal: | |
| Formato: | Artículo |
| Publicado: |
Wiley-Blackwell
Jan2026
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |